Position in LLY
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$85,404,323
-$7,787,636 QoQ
Shares Held
92,854
+7.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Artemis Investment Management LLP holds $1,107,485,466 across 8 Drug Manufacturers - General names. LLY ranks #6 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,444,565 | $284,897,109 | |
| 2 | ABBV |
AbbVie Inc.
|
1,041,483 | $226,512,137 | |
| 3 | PFE |
Pfizer Inc
|
7,392,508 | $207,581,624 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,885,298 | $174,993,323 | |
| 5 | BIIB |
Biogen Inc.
|
571,571 | $104,786,111 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
92,854 | $85,404,323 | |
| 7 | JNJ |
Johnson & Johnson
|
65,168 | $15,929,665 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
52,961 | $7,381,174 |
All Filings in LLY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $85,404,323 | 92,854 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $93,191,959 | 86,716 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $28,353,843 | 37,161 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $56,201,774 | 72,097 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $61,999,411 | 75,068 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $46,559,320 | 60,310 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $49,146,635 | 55,474 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $38,664,252 | 42,705 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $51,250,448 | 65,878 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $38,835,879 | 66,623 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $56,990,567 | 106,102 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $54,303,663 | 115,791 | Shares | Sole | 2023-07-19 | |
| 2022-03-31 | $27,212,595 | 95,026 | Shares | Sole | 2022-04-21 | |
| 2020-09-30 | $5,656,436 | 38,214 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $6,762,410 | 41,189 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $3,734,064 | 26,918 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||